|
Insider Trading: Nxstage Medical, Inc.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nxstage Medical, Inc. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Nxstage Medical, Inc. since year 2005. Table 2 shows the detailed insider transactions of Nxstage Medical, Inc. since 2005.
The reporting company's ticker symbol is NXTM.
The reporting company's CIK number is 1333170.
The total value of stock buying since 2005 is $43,308,597.
The total value of stock sales is $646,073.
The total value of stock exercises is $11,902.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Nxstage Medical, Inc. (NXTM) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Nxstage Medical, Inc. (NXTM) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Nxstage Medical, Inc. (NXTM).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 1,194,922 | 5,188,995 | 32,170 | 121,671 | 32,170 | 11,902 |
| 2008-05 | 5,555,556 | 25,000,002 | 0 | 0 | 0 | 0 |
| 2006-06 | 700,000 | 6,125,000 | 54,711 | 449,997 | 0 | 0 |
| 2006-05 | 0 | 0 | 6,795 | 74,405 | 0 | 0 |
| 2005-10 | 699,460 | 6,994,600 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Nxstage Medical, Inc. (NXTM)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-26 | Isaly Samuel D (Director) | Purchase | 27,700 | 3.50 | 97,052 |
| 2008-08-25 | Isaly Samuel D (Director) | Purchase | 108,900 | 3.37 | 367,112 |
| 2008-08-21 | Isaly Samuel D (Director) | Purchase | 26,100 | 3.25 | 84,832 |
| 2008-08-21 | Phildius Peter P (Director) | Sale | 13,570 | 3.28 | 44,510 |
| 2008-08-13 | Phildius Peter P (Director) | Sale | 6,500 | 4.03 | 26,208 |
| 2008-08-12 | Moore Craig W (Director) | Purchase | 10,000 | 4.00 | 40,000 |
| 2008-08-11 | Phildius Peter P (Director) | Sale | 12,100 | 4.21 | 50,953 |
| 2008-08-11 | Phildius Peter P (Director) | Option Exercise | 32,170 | .37 | 11,902 |
| 2008-08-01 | Credit Suisse/ (10% Owner) | Purchase | 1,022,222 | 4.50 | 4,599,999 |
| 2008-05-23 | Isaly Samuel D (Director) | Purchase | 5,555,556 | 4.50 | 25,000,002 |
| 2006-06-09 | Chambon Philippe (Director) | Purchase | 350,000 | 8.75 | 3,062,500 |
| 2006-06-09 | Credit Suisse/ (10% Owner) | Purchase | 350,000 | 8.75 | 3,062,500 |
| 2006-06-08 | Burbank Jeffrey H (President & CEO) | Sale | 54,711 | 8.22 | 449,997 |
| 2006-05-26 | Atlas Venture Associates Iii L P (10% Owner) | Sale | 6,795 | 10.95 | 74,405 |
| 2005-10-27 | Utterberg David S (Director) | Purchase | 73,789 | 10.00 | 737,890 |
| 2005-10-27 | Chambon Philippe (Director) | Purchase | 187,035 | 10.00 | 1,870,350 |
| 2005-10-27 | Reid Perper (Director) | Purchase | 51,755 | 10.00 | 517,550 |
| 2005-10-27 | Atlas Venture Associates V Lp (10% Owner) | Purchase | 99,923 | 10.00 | 999,230 |
| 2005-10-27 | Formela Jean Francois | Purchase | 99,923 | 10.00 | 999,230 |
| 2005-10-27 | Credit Suisse First Boston/ (Other) | Purchase | 187,035 | 10.00 | 1,870,350 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Nxstage Medical, Inc. (symbol NXTM,
CIK number 1333170) see
the Securities and Exchange Commission (SEC) website.
|
|
